469 related articles for article (PubMed ID: 29570945)
21. High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer.
Park KS; Moon YW; Raffeld M; Lee DH; Wang Y; Giaccone G
Lung Cancer; 2018 Feb; 116():38-45. PubMed ID: 29413049
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
23. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
24. Expression and prognostic value of Cripto-1 in early non-small cell lung cancer.
Zhong J; Li L; Zhang Q; Zou J; Liu W; Xu CH
Clin Respir J; 2023 Dec; 17(12):1203-1208. PubMed ID: 37528674
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
26. Serological investigation of the clinical significance of fascin in non-small-cell lung cancer.
Teng Y; Xu S; Yue W; Ma L; Zhang L; Zhao X; Guo Y; Zhang C; Gu M; Wang Y
Lung Cancer; 2013 Nov; 82(2):346-52. PubMed ID: 24070574
[TBL] [Abstract][Full Text] [Related]
27. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer.
Xu CH; Zhang Y; Yu LK
Tumour Biol; 2014 Jun; 35(6):5199-203. PubMed ID: 24510347
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.
Cho A; Hur J; Hong YJ; Lee HJ; Kim YJ; Hong SR; Suh YJ; Im DJ; Kim YJ; Lee JS; Shim HS; Choi BW
Tumour Biol; 2016 Mar; 37(3):3205-13. PubMed ID: 26432331
[TBL] [Abstract][Full Text] [Related]
31. Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
Zhang YK; Sun B; Sui G
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525941
[TBL] [Abstract][Full Text] [Related]
32. Clinical and prognostic importance of XIAP and USP8 in advanced stages of non-small cell lung cancer.
Baykara M; Yaman M; Buyukberber S; Tufan G; Demirci U; Benekli M; Coskun U; Ozet A; Umit Bagriacik E
J BUON; 2013; 18(4):921-7. PubMed ID: 24344018
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
Liu L; Qu W; Zhong Z
Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
[TBL] [Abstract][Full Text] [Related]
34. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
35. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.
Wang K; Dong L; Fang Q; Xia H; Hou X
Cancer Biomark; 2017 Sep; 20(3):283-288. PubMed ID: 28946561
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
37. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group.
Tanriverdi O; Avci N; Oktay E; Kalemci S; Pilanci KN; Cokmert S; Menekse S; Kocar M; Sen CA; Akman T; Ordu C; Goksel G; Meydan N; Barutca S
Asian Pac J Cancer Prev; 2015; 16(14):5971-6. PubMed ID: 26320482
[TBL] [Abstract][Full Text] [Related]
40. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Fan W; Yang H; Xue H; Sun Y; Zhang J
Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
